Lightnews — Scholar-powered news

Janany S @glomerican.bsky.social · 3d

amen!!!!!! 🙏 #nephjc

Janany S @glomerican.bsky.social · 4d

Alot of the time my diabetic CKD patients end up getting poor glycemic control as a result if the low protein diet, I find i usually go head to head with endocrinology regarding this specific topic. Can anyone relate ? Just flozinate i guess 🙃 #NephJC

1 1 3

Janany S @glomerican.bsky.social · 4d

Janany Sabescumar no COI #nephJC

6

Reposted by Janany S

Edgar V. Lerma 🇵🇭 @edgarvlermamd.bsky.social · 19d

Decision support for PICC Line placement in patients with CKD ca. 2023
#Nephpearls #VascularAccessPearls #NephSky

#VisualGraphic by @brianrifkin.bsky.social

👉🏼 pubmed.ncbi.nlm.nih.gov/34218708/

1 3 4

Reposted by Janany S

Nephrology Journal Club @nephjc.bsky.social · 20d

Chimerism might just be the 🔑 to immune tolerance and ending the need for immunosuppression 🚫💊after transplantation 🫘.
Join the discussion 9/30/25 at 9 pm EST on Bluesky #NephSky #MedSky #NephJC
www.nephjc.com/news/chimera-tolerance-njqe334

Chimerism and Immune Tolerance: Can We Says Goodbye to Immunosuppression? — NephJC

This week, we will discuss the use of creating chimeras to induce immune tolerance and its potential to decrease or eliminate the need for immunosuppression in kidney transplant recipients.

www.nephjc.com

12 16

Janany S @glomerican.bsky.social · 25d

sweet!

Reposted by Janany S

Nephrology Journal Club @nephjc.bsky.social · 27d

It's that time of year again 🍂🍂🍂
The #NephJC Fall pledge drive.
Plese give if you are able to support our decades long mission of #FOAMed for all. #NephSky #MedSky
www.nephjc.com/news/2025/9/22/nephjc-fall-pledge-drive

NephJC 2025 Fall Pledge Drive — NephJC

Help keep NephJC a vital, original, and unbiased source of medical education.

www.nephjc.com

12 15

Janany S @glomerican.bsky.social · Sep 17

flashbacks from intern year asking for IV hydralazine for asymptomatic HTN 🥲🥲

Reposted by Janany S

glomcon.org @glomcon.org · Jul 28

#GlomConHawaii 2025 🌴🌊 session: EMBARK Awareness - Closing the Gaps: Unmet Needs and Rising Opportunities for Community Education and Engagement

Register here 👉 glomconhawaii.org

#GlomConHawaii2025
#GlomConHawaii
#GlomCon

1 1

Reposted by Janany S

Nephrology Journal Club @nephjc.bsky.social · Sep 16

❤️Check out the VA for the discussion on the AHA/ACC Hypertension Guidelines 9/16/25 at 9pm EST by @sejalplakhani.bsky.social #NephJC #NephSky #MedSky
www.nephjc.com/news/2025/9/ahaacc-htnguide

The AHA/ACC 2025 Hypertension Guidelines visual abstract — NephJC

New updated guidance on hypertension including screening for secondary causes, use of renal denervation, hypertension and pregnancy, risk assessment, monitoring and treatment. Check out this wonderfu...

www.nephjc.com

14 19

Reposted by Janany S

Swapnil Hiremath 🍁🇨🇦 @hswapnil.medsky.social · Sep 16

Agree with this algorithm from evidence.nejm.org/doi/full/10.... ($$$ or sub reqd)

Flozinate and Glipinate

Metformin only if these are not appropriate or possible

All else comes later

Algorithm for management of diabetes with flozins and GLP1RAs as mainstay

2 3 8

Janany S @glomerican.bsky.social · Sep 3

I wonder if dialysis vintage should have been accounted for, more frequent dialysis using PD may have higher CV benefits more UF, less likely to have HF exacerbation ?

Reposted by Janany S

Brian Rifkin @brianrifkin.bsky.social · Sep 1

Join us #NephJC #NephSky

Nephrology Journal Club @nephjc.bsky.social · Sep 1

Check out the ACHIEVE visual abstract by @nephromommy-akshu.bsky.social

www.nephjc.com/news/2025/8/...

The ACHIEVE visual abstract — NephJC

the use of spironolactone in patients on dialysis did not alter mortality or hospitalizations for heart failure. Similar results were seen in the simultaneously released ALCHEMY trial.

www.nephjc.com

2 4 2

Reposted by Janany S

Nephrology Journal Club @nephjc.bsky.social · Sep 1

Check out the ACHIEVE visual abstract by @nephromommy-akshu.bsky.social

www.nephjc.com/news/2025/8/...

The ACHIEVE visual abstract — NephJC

the use of spironolactone in patients on dialysis did not alter mortality or hospitalizations for heart failure. Similar results were seen in the simultaneously released ALCHEMY trial.

www.nephjc.com

1 6 10

Reposted by Janany S

Nephrology Journal Club @nephjc.bsky.social · Aug 6

T0b
Expert opinion—not RCTs—has dominated guidelines on phosphorus control in ESRD for decades. Why? Because phosphate feels like a villain... but is it really? 🦹‍♂️ I can feel it in my bones. #NephJC

2 2 8

Reposted by Janany S

Nephrology Journal Club @nephjc.bsky.social · Jul 23

Check the insightful #NephJC summary by Akshaya Jayachandran ‪@nephromommy-akshu.bsky.social, Natalia Nombera @roxnonna23.bsky.social, Janany Sabescumar @glomerican.bsky.social

www.nephjc.com/news/...

1 3 9

Janany S @glomerican.bsky.social · Jul 23

higher cardiovascular risk, mortality/morbitity with low eGFR

im definitely more alert when the patient’s cystatin C based eGFR is much lower, and ask for more frequent follow up

1 1

Reposted by Janany S

Nephrology Journal Club @nephjc.bsky.social · Jul 21

On 7/22/25 at 9pm EST only on Bluesky!
#NephSky #MedSky join us for a lively discussion.
We're debating eGFRdiff (the gap that is sometimes present between the eGFR of cystatin C and creatinine). What does it mean, what causes it and what you should do about it. #NephJC
www.nephjc.com/news/egfrdiff

Mind The Gap: When eGFR Creatinine and Cystatin C Disagree — NephJC

This week, we will discuss the clinical significance of eGFRdiff, the difference in eGFRcys (cystatin C) and eGFRcr (creatinine).

www.nephjc.com

22 37

Reposted by Janany S

Alicja Rosołowska @alunieczka.bsky.social · Jul 6

As always the @nephjc.bsky.social summer book turns out to be a great and fascinating read. Highly recommended.

7 13

Reposted by Janany S

Nephrology Journal Club @nephjc.bsky.social · Jul 7

🎨Check out the beautiful #visualabstract by #NephJC intern @shelliefravel.bsky.social

⏰Chat happening on July 8, 9 pm EST

www.nephjc.com/news/2025/7/...

CONFIDENCE Visual Abstract — NephJC

Check out the beautiful visual abstract made by NephJC intern Michelle Fravel .

www.nephjc.com

1 14 16

Reposted by Janany S

Nephrology Journal Club @nephjc.bsky.social · Jun 25

1/10
Last #NephJC we discussed tacrolimus (TAC) versus mycophenolate mofetil (MMF) for the treatment of pediatric nephrotic syndrome. A first👶to👶immunosuppression study for SSNS in kids #TenPostNephJC .
Read the articles 👇
pmc.ncbi.nlm.nih.gov/articles/PMC...